-
Gene Sequencing Diagnoses Paralympic Hopeful's Rare Disease
Tuesday, June 18, 2013
UK national cycling champion Tom Staniford suffers from an extremely rare genetic disease that went undiagnosed until nowFor years, Tom Staniford has defied the odds, becoming a national cycling champion in Great Britain despite a debilitating illnessNow, researchers have learned what's causing h
-
John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations
Tuesday, June 18, 2013
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced today that John Northcott has joined the company as its vice president of marketing, commercial strategy, and operations. Mr. Northcott brings extensive commercial
-
Six-Month-Old English Baby With Rare Chromosomal Disorder Emanuel Syndrome to Rejoin Parents
Tuesday, June 18, 2013
April Karmazyn-Wall, a six-month-old baby suffering from the extremely rare genetic disorder Emanuel syndrome, may soon be joining her parents at home in Wallsend, a town in North Tyneside, England, Chronicle Live reportsCaused by an extra chromosome called derivative 22 referred to as der(22), Em
-
Evaluate Launches Enhanced Orphan Drug Intelligence
Tuesday, June 18, 2013
The worldwide orphan drug market is set to reach $127 billion by 2018, accounting for nearly 16 percent of total prescription drug sales, according to the recently released Orphan Drug Report 2013 from EvaluateTo better serve its clients' needs in regard to this growing segment of the pharmaceutic
-
Native American Myopathy: A Breakthrough in Rare Disease That Only Affects Lumbees
Tuesday, June 18, 2013
PROSPECT - When her son, Gene, was only a few days old, Cassandra Locklear said doctors labeled him with a foreboding prognosis: "failure to thriveThe muscles in his mouth were so weak that he couldn't suck a bottle, Locklear saidDoctors weren't sure what was wrong, and, without the ability to ge
-
Roche’s Avastin Approved in Japan for Treatment of the Most Aggressive Form of Brain Cancer
Tuesday, June 18, 2013
Roche announced that the Japanese Ministry of Health, Labour and Welfare has approved Avastin for the treatment of malignant glioma, including newly diagnosed glioblastoma in combination with radiotherapy and temozolomide chemotherapy, and as monotherapy for treatment of recurrent GBM and certain
-
AbbVie Presents Preliminary Results From Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
Tuesday, June 18, 2013
AbbVie announced preliminary results from a Phase I study of ABT-199/GDC-0199, an investigational BCL-2 (B-cell lymphoma 2) selective inhibitor, in patients with high-risk relapsed/refractory chronic lymphocytic leukemia (CLL), and in patients with relapsed/refractory non-Hodgkin's lymphoma (NHL).
-
Animal Thyroid Extract as Effective as T4 in Treating Hypothyroidism
Tuesday, June 18, 2013
Desiccated thyroid extract (DTE), derived from crushed preparations of animal thyroid glands, is a safe and effective alternative to standard T4 therapy in hypothyroid patients, a new study finds. The results will be presented at The Endocrine Society's 95th Annual Meeting in San FranciscoIn adult
-
NIH Scientists Find Promising Biomarker for Predicting HPV-related Oropharynx Cancer
Tuesday, June 18, 2013
Researchers have found that antibodies against the human papillomavirus (HPV) may help identify individuals who are at greatly increased risk of HPV-related cancer of the oropharynx, which is a portion of the throat that contains the tonsilsIn their study, at least 1 in 3 individuals with orophary
-
Certain Types of Graft-Versus-Host Disease May Increase Risk of Death, Moffitt Cancer Center Researcher Says
Tuesday, June 18, 2013
Joseph Pidala, M.D., M.S., assistant member of the Blood and Bone Marrow Transplant and Immunology programs at Moffitt Cancer Center, and colleagues from the Chronic Graft-Versus-Host Disease Consortium have determined that certain gastrointestinal and liver-related types of chronic graft-versus-T